Tested Applications
| Positive WB detected in | A549 cells, pig spleen tissue, HepG2 cells, THP-1 cells, human peripheral blood leukocytes |
| Positive IHC detected in | human tonsillitis tissue Note: suggested antigen retrieval with TE buffer pH 9.0; (*) Alternatively, antigen retrieval may be performed with citrate buffer pH 6.0 |
Recommended dilution
| Application | Dilution |
|---|---|
| Western Blot (WB) | WB : 1:500-1:1000 |
| Immunohistochemistry (IHC) | IHC : 1:20-1:200 |
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
Product Information
11461-1-AP targets LILRA2 in WB, IHC, ELISA applications and shows reactivity with human, pig samples.
| Tested Reactivity | human, pig |
| Cited Reactivity | mouse, rat |
| Host / Isotype | Rabbit / IgG |
| Class | Polyclonal |
| Type | Antibody |
| Immunogen |
CatNo: Ag2003 Product name: Recombinant human LILRA2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 1-400 aa of BC017412 Sequence: MTPILTVLICLGLSLGPRTHVQAGHLPKPTLWAEPGSVIIQGSPVTLRCQGSLQAEEYHLYRENKSASWVRRIQEPGKNGQFPIPSITWEHAGRYHCQYYSHNHSSEYSDPLELVVTGAYSKPTLSALPSPVVTLGGNVTLQCVSQVAFDGFILCKEGEDEHPQRLNSHSHARGWSWAIFSVGPVSPSRRWSYRCYAYDSNSPYVWSLPSDLLELLVPGVSKKPSLSVQPGPMVAPGESLTLQCVSDVGYDRFVLYKEGERDFLQRPGWQPQAGLSQANFTLGPVSPSHGGQYRCYSAHNLSSEWSAPSDPLDILITGQFYDRPSLSVQPVPTVAPGKNVTLLCQSRGQFHTFLLTKEGAGHPPLHLRSEHQAQQNQAEFRMGPVTSAHVGTYRCYSSLS Predict reactive species |
| Full Name | leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2 |
| Calculated Molecular Weight | 466 aa, 51 kDa |
| Observed Molecular Weight | 53 kDa |
| GenBank Accession Number | BC017412 |
| Gene Symbol | LILRA2 |
| Gene ID (NCBI) | 11027 |
| RRID | AB_2136370 |
| Conjugate | Unconjugated |
| Form | Liquid |
| Purification Method | Antigen affinity purification |
| UNIPROT ID | Q8N149 |
| Storage Buffer | PBS with 0.02% sodium azide and 50% glycerol, pH 7.3. |
| Storage Conditions | Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. 20ul sizes contain 0.1% BSA. |
Protocols
| Product Specific Protocols | |
|---|---|
| IHC protocol for LILRA2 antibody 11461-1-AP | Download protocol |
| WB protocol for LILRA2 antibody 11461-1-AP | Download protocol |
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols |
Publications
What published studies show
The LILRA2 Polyclonal antibody (Catalog No. 11461-1-AP) has a total of 2 citations. These appear in the journals Phytomedicine (2021) and Free Radical Biology and Medicine (2020). The associated research fields include reproductive biology—specifically cyclophosphamide-induced ovarian damage and follicular atresia—and renal/mitochondrial biology, examining proximal tubule fatty acid utilization, mitophagy, and mitochondrial biogenesis in experimental Fanconi syndrome. Both studies applied the antibody for Western blot analysis in mouse and rat models, respectively.
| Species | Application | Title |
|---|---|---|
Phytomedicine Epigallocatechin gallate and theaflavins independently alleviate cyclophosphamide-induced ovarian damage by inhibiting the overactivation of primordial follicles and follicular atresia. | ||
Free Radic Biol Med Altered proximal tubule fatty acid utilization, mitophagy, fission and supercomplexes arrangement in experimental Fanconi syndrome are ameliorated by sulforaphane-induced mitochondrial biogenesis. |







